<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>FT.com - Drugs and Healthcare via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'FT.com - Drugs and Healthcare' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=FT.com+-+Drugs+and+Healthcare&t=FT.com+-+Drugs+and+Healthcare&s=Search&f=source]]></link>
        <lastBuildDate>Tue, 16 Mar 2010 16:37:16 +0100</lastBuildDate>
        <item>
            <title>Siemens to pull plug on hearing aid unit sale</title>
            <link>http://www.medworm.com/index.php?rid=3368420&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F18a11366-305c-11df-bc4a-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Europe's largest engineering group is set to pull the plug on the sale of its hearing aids division, after offers for the market-leading business did not match expectations (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368420</comments>
            <pubDate>Mon, 15 Mar 2010 22:46:36 +0100</pubDate>
            <guid isPermaLink="false">3368420</guid>        </item>
        <item>
            <title>Making a virtue of patients</title>
            <link>http://www.medworm.com/index.php?rid=3368421&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F44b0f7ac-305f-11df-bc4a-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A new project to tackle bureaucracy in drugs trials hopes to reverse the UK's decline as a centre of pharmaceutical development (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368421</comments>
            <pubDate>Mon, 15 Mar 2010 22:15:23 +0100</pubDate>
            <guid isPermaLink="false">3368421</guid>        </item>
        <item>
            <title>Smith &amp; Nephew's growing pains</title>
            <link>http://www.medworm.com/index.php?rid=3365075&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F77f06080-2f92-11df-9153-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The chief executive of the orthopaedics company is drawing on the expertise of a former executive at Federal Express, the logistics group, to drive its expansion (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365075</comments>
            <pubDate>Mon, 15 Mar 2010 02:08:33 +0100</pubDate>
            <guid isPermaLink="false">3365075</guid>        </item>
        <item>
            <title>Patients' groups distrust 'big pharma'</title>
            <link>http://www.medworm.com/index.php?rid=3356829&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fcc0714ac-2d62-11df-a262-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Detailed rankings compiled from patient groups showed many continental European groups rated highly, while US and UK businesses were less well judged (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3356829</comments>
            <pubDate>Fri, 12 Mar 2010 03:10:10 +0100</pubDate>
            <guid isPermaLink="false">3356829</guid>        </item>
        <item>
            <title>AstraZeneca ties up with Indian drugmaker</title>
            <link>http://www.medworm.com/index.php?rid=3356828&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc4499166-2d0f-11df-8025-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The alliance with Torrent Pharmaceuticals is the first step in the Anglo-Swedish pharmaceutical group's plans to rapidly expand sales of generic drugs (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3356828</comments>
            <pubDate>Fri, 12 Mar 2010 03:10:10 +0100</pubDate>
            <guid isPermaLink="false">3356828</guid>        </item>
        <item>
            <title>DFID cash boost for vaccines fund</title>
            <link>http://www.medworm.com/index.php?rid=3356830&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F626f5c2e-2d77-11df-a262-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Department for International Development (DFID) has given £150m over the next decade to support the Global Alliance on Vaccines and Immunisations, a United... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3356830</comments>
            <pubDate>Fri, 12 Mar 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3356830</guid>        </item>
        <item>
            <title>Sanofi joins Merck in animal health venture</title>
            <link>http://www.medworm.com/index.php?rid=3348706&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fb8b67398-2baf-11df-a5c7-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The pharmaceutical group has agreed a deal to establish a joint venture with Merck which will be the world's largest animal health business (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3348706</comments>
            <pubDate>Tue, 09 Mar 2010 23:34:30 +0100</pubDate>
            <guid isPermaLink="false">3348706</guid>        </item>
        <item>
            <title>Bupa's Asia growth mitigates UK, US slowness</title>
            <link>http://www.medworm.com/index.php?rid=3348707&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff69b8d24-2b5f-11df-9d96-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Strong growth in customer numbers in Asia and the acquisition of MBF, the Australian insurer, helps mitigate sluggish performance of the medical insurance group in the US and UK (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3348707</comments>
            <pubDate>Tue, 09 Mar 2010 16:56:17 +0100</pubDate>
            <guid isPermaLink="false">3348707</guid>        </item>
        <item>
            <title>Sanofi and Merck to combine animal divisions</title>
            <link>http://www.medworm.com/index.php?rid=3345030&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Facb9d61e-2b66-11df-9d96-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>French and US pharmaceutical groups agree to join their animal health operations, creating a joint venture with nearly $5.3bn in annual sales (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3345030</comments>
            <pubDate>Tue, 09 Mar 2010 11:58:43 +0100</pubDate>
            <guid isPermaLink="false">3345030</guid>        </item>
        <item>
            <title>Regulator finds ethics breach by AstraZeneca</title>
            <link>http://www.medworm.com/index.php?rid=3345031&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc790d064-2aee-11df-886b-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A UK regulatory panel says the pharmaceutical group failed to accurately reflect the side effects of its top-selling antipsychotic drug Seroquel in an advertisement to doctors (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3345031</comments>
            <pubDate>Mon, 08 Mar 2010 22:10:09 +0100</pubDate>
            <guid isPermaLink="false">3345031</guid>        </item>
        <item>
            <title>AstraZeneca job cuts reflect new landscape</title>
            <link>http://www.medworm.com/index.php?rid=3345032&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F8711080a-2ae0-11df-886b-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Anglo-Swedish pharmaceuticals group's move is latest in series of shake-ups that will have a key impact on the volume of medical innovation (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3345032</comments>
            <pubDate>Mon, 08 Mar 2010 18:57:54 +0100</pubDate>
            <guid isPermaLink="false">3345032</guid>        </item>
        <item>
            <title>Scottish start-up in £70m Sinopharm deal</title>
            <link>http://www.medworm.com/index.php?rid=3340986&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F5e84b3e8-2a43-11df-b940-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Under the partnership agreement, the Chinese pharmaceutical distributor will undertake the regulatory compliance process in Beijing for Burdica Biomed's range of personal lubricants (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3340986</comments>
            <pubDate>Mon, 08 Mar 2010 01:18:45 +0100</pubDate>
            <guid isPermaLink="false">3340986</guid>        </item>
        <item>
            <title>3i buys majority stake in health chain</title>
            <link>http://www.medworm.com/index.php?rid=3337124&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F403304f6-2883-11df-a0b1-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK's oldest private equity firm feels it has recovered sufficiently from the financial crisis to return to the dealmaking fray (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3337124</comments>
            <pubDate>Fri, 05 Mar 2010 23:12:14 +0100</pubDate>
            <guid isPermaLink="false">3337124</guid>        </item>
        <item>
            <title>Care UK goes private via Bridgepoint</title>
            <link>http://www.medworm.com/index.php?rid=3329404&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F80531dd4-271e-11df-b84e-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The all-cash offer of 450p a share from private equity group Bridgepoint represents a premium and values the provider of nursing and elderly home care at £423m (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3329404</comments>
            <pubDate>Thu, 04 Mar 2010 02:15:53 +0100</pubDate>
            <guid isPermaLink="false">3329404</guid>        </item>
        <item>
            <title>Inquiry into NHS provider rule halted</title>
            <link>http://www.medworm.com/index.php?rid=3329403&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F136df3e8-2704-11df-8c08-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Primary care health trusts across the east of England have been ordered to suspend procurement for community services (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3329403</comments>
            <pubDate>Thu, 04 Mar 2010 02:15:53 +0100</pubDate>
            <guid isPermaLink="false">3329403</guid>        </item>
        <item>
            <title>Four Seasons faces new creditor talks</title>
            <link>http://www.medworm.com/index.php?rid=3325263&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F97107f7c-260a-11df-b2fc-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>One of the UK's largest care group is set to be dragged back into talks after a group of bondholders threatened to block an attempt to renegotiate the terms of its debts (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325263</comments>
            <pubDate>Wed, 03 Mar 2010 02:53:25 +0100</pubDate>
            <guid isPermaLink="false">3325263</guid>        </item>
        <item>
            <title>Barclays Private Equity to sell Deb Group</title>
            <link>http://www.medworm.com/index.php?rid=3325259&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F493568d8-2639-11df-aff3-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Buy-out company is to announce the sale of the cleaning products maker to Charterhouse in a deal worth £325m (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325259</comments>
            <pubDate>Wed, 03 Mar 2010 02:53:25 +0100</pubDate>
            <guid isPermaLink="false">3325259</guid>        </item>
        <item>
            <title>Ratiopharm sale in final stages</title>
            <link>http://www.medworm.com/index.php?rid=3325264&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7e2db7a6-2653-11df-aff3-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Teva Pharmaceutical Industries of Israel, Actavis of Iceland and Pfizer of the US are said to be vying to win control of the German generic drug company in the €3bn auction (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325264</comments>
            <pubDate>Wed, 03 Mar 2010 01:26:46 +0100</pubDate>
            <guid isPermaLink="false">3325264</guid>        </item>
        <item>
            <title>AstraZeneca to halt leading disease research</title>
            <link>http://www.medworm.com/index.php?rid=3325260&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fa1fc96ea-2629-11df-aff3-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Anglo-Swedish group to cease research into several diseases that have generated its largest selling drugs (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325260</comments>
            <pubDate>Tue, 02 Mar 2010 22:48:20 +0100</pubDate>
            <guid isPermaLink="false">3325260</guid>        </item>
        <item>
            <title>Astellas raises OSI bid pressure</title>
            <link>http://www.medworm.com/index.php?rid=3325261&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F935c577e-2638-11df-aff3-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Japanese pharmaceutical company intensified the pressure of its hostile $3.5bn bid for OSI with a legal action designed to prevent its US target from issuing a poison pill (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325261</comments>
            <pubDate>Tue, 02 Mar 2010 22:44:57 +0100</pubDate>
            <guid isPermaLink="false">3325261</guid>        </item>
        <item>
            <title>HgCapital says Goldshield understated profits</title>
            <link>http://www.medworm.com/index.php?rid=3325262&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fed52c9e6-263f-11df-aff3-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Private equity group appoints lawyers and accountants to investigate whether drugmaker it bought understated profits while a listed comany (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3325262</comments>
            <pubDate>Tue, 02 Mar 2010 21:24:25 +0100</pubDate>
            <guid isPermaLink="false">3325262</guid>        </item>
        <item>
            <title>Merck move reflects sector's push to diversify</title>
            <link>http://www.medworm.com/index.php?rid=3320312&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F87c0ac3c-2569-11df-9cdb-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Merck's planned $7.2bn takeover of Millipore adds a German twist to the intensifying climate of consolidation in the pharmaceuticals industry (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3320312</comments>
            <pubDate>Tue, 02 Mar 2010 11:40:36 +0100</pubDate>
            <guid isPermaLink="false">3320312</guid>        </item>
        <item>
            <title>Astellas in $3.5bn bid to expand role in US</title>
            <link>http://www.medworm.com/index.php?rid=3320311&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F82c53b3a-255f-11df-9cdb-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Japanese pharmaceuticals company has launched a hostile bid for OSI Pharmaceuticals, offering $3.5bn in a deal designed to expand its US presence and activities in oncology (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3320311</comments>
            <pubDate>Tue, 02 Mar 2010 11:40:36 +0100</pubDate>
            <guid isPermaLink="false">3320311</guid>        </item>
        <item>
            <title>UK receives venture capital boost</title>
            <link>http://www.medworm.com/index.php?rid=3320313&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F0f09eb7e-2563-11df-9cdb-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The sector gets a double lift from the $330m sale of a biotechnology company to a US pharmaceutical group and a £65m fundraising round by a developer of painkillers for cancer patients (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3320313</comments>
            <pubDate>Mon, 01 Mar 2010 23:48:13 +0100</pubDate>
            <guid isPermaLink="false">3320313</guid>        </item>
        <item>
            <title>Genus interim profits fall</title>
            <link>http://www.medworm.com/index.php?rid=3309576&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F36f472e0-221f-11df-9a72-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK animal genetics company reports a fall in revenue, with the global agricultural recession forcing customers to postpone updating the genetic profile of their herds (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3309576</comments>
            <pubDate>Fri, 26 Feb 2010 04:18:53 +0100</pubDate>
            <guid isPermaLink="false">3309576</guid>        </item>
        <item>
            <title>Nintendo's move</title>
            <link>http://www.medworm.com/index.php?rid=3309577&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2d59efea-2278-11df-a93d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Tech Blog (Chris Nuttall): Nintendo is moving closer to eReader and iPad territory with the launch of a large-screen version of its DS handheld console. The... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3309577</comments>
            <pubDate>Fri, 26 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3309577</guid>        </item>
        <item>
            <title>NHS managers 'need disciplinary body'</title>
            <link>http://www.medworm.com/index.php?rid=3304766&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff1f31136-217b-11df-830e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Senior management should be turned into a profession, with an independent disciplinary body, says the latest inquiry into the Mid-Staffordshire NHS Foundation Trust (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304766</comments>
            <pubDate>Wed, 24 Feb 2010 19:43:51 +0100</pubDate>
            <guid isPermaLink="false">3304766</guid>        </item>
        <item>
            <title>Pharma groups team up on cancer research</title>
            <link>http://www.medworm.com/index.php?rid=3300333&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff8dc5a42-20a5-11df-9775-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Eli Lilly, Merck and Pfizer launch the Asian Cancer Research Group, a ground-breaking joint venture designed to research new treatments for lung and gastric cancer (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3300333</comments>
            <pubDate>Wed, 24 Feb 2010 02:24:58 +0100</pubDate>
            <guid isPermaLink="false">3300333</guid>        </item>
        <item>
            <title>3i sells Nordic healthcare group for €850m</title>
            <link>http://www.medworm.com/index.php?rid=3296688&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fbb1b711a-206f-11df-bf2d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Buy-out group 3i sells Ambea, a Nordic hospital and nursing homes operator, for €850m to Triton, a German private equity group, in the latest sign that debt markets are prepared to finance deals (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296688</comments>
            <pubDate>Tue, 23 Feb 2010 12:23:31 +0100</pubDate>
            <guid isPermaLink="false">3296688</guid>        </item>
        <item>
            <title>AstraZeneca pays £505m to settle tax row</title>
            <link>http://www.medworm.com/index.php?rid=3300334&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F52f74244-2051-11df-bf2d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Anglo-Swedish drugs group settles long-running dispute with the UK tax authorities over the contentious issue of transfer pricing, allowing it to raise earnings guidance for the year (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3300334</comments>
            <pubDate>Tue, 23 Feb 2010 11:35:10 +0100</pubDate>
            <guid isPermaLink="false">3300334</guid>        </item>
        <item>
            <title>Reckitt accused of market abuse</title>
            <link>http://www.medworm.com/index.php?rid=3296689&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fb3d41b42-2055-11df-bf2d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Office of Fair Trading accuses the group of abusing its dominant position in the market to supply the NHS with heartburn medicine (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296689</comments>
            <pubDate>Tue, 23 Feb 2010 11:21:05 +0100</pubDate>
            <guid isPermaLink="false">3296689</guid>        </item>
        <item>
            <title>White House tilts at barrier to cheap drugs</title>
            <link>http://www.medworm.com/index.php?rid=3296690&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F8deb2470-2000-11df-81a2-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Obama administration's healthcare proposal would prohibit big branded drug makers from agreeing multibillion-dollar deals with rivals in the generic industry that keep cheaper drugs off the market (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296690</comments>
            <pubDate>Mon, 22 Feb 2010 22:30:27 +0100</pubDate>
            <guid isPermaLink="false">3296690</guid>        </item>
        <item>
            <title>MPs urge NHS to stop funding homeopathy</title>
            <link>http://www.medworm.com/index.php?rid=3296691&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fe1938d22-1fdf-11df-8deb-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The National Health Service should stop funding homeopathy and the medicines regulator should no longer license its products, a group of MPs recommended. The Commons' science and technology committee said the evidence showed it was not effective (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296691</comments>
            <pubDate>Mon, 22 Feb 2010 18:43:35 +0100</pubDate>
            <guid isPermaLink="false">3296691</guid>        </item>
        <item>
            <title>US Senate questions regulators on GSK drug</title>
            <link>http://www.medworm.com/index.php?rid=3293228&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F1ce61dee-1f37-11df-9584-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Lawmakers demand the FDA explain why it permitted the pharmaceutical group to proceed with a clinical trial of diabetes drug Avandia in spite of knowledge of higher cardiac risks (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3293228</comments>
            <pubDate>Mon, 22 Feb 2010 09:03:54 +0100</pubDate>
            <guid isPermaLink="false">3293228</guid>        </item>
        <item>
            <title>Drugmakers set to win softer terms from Manila</title>
            <link>http://www.medworm.com/index.php?rid=3293227&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F413ac1b2-1f65-11df-9584-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Global drugmakers in the Philippines are poised to win softer terms than expected from the government for a fresh round of price cuts on essential medicines (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3293227</comments>
            <pubDate>Mon, 22 Feb 2010 09:03:54 +0100</pubDate>
            <guid isPermaLink="false">3293227</guid>        </item>
        <item>
            <title>PwC finds the doctor knows best</title>
            <link>http://www.medworm.com/index.php?rid=3293229&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F15e1f430-1f52-11df-9584-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>What can an accounting firm learn from a hospital? Quite a lot, says Jared Bleak, executive director at Duke Corporate Education, at Duke University's Fuqua School of... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3293229</comments>
            <pubDate>Mon, 22 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3293229</guid>        </item>
        <item>
            <title>Competition in NHS makes hospitals better, study says</title>
            <link>http://www.medworm.com/index.php?rid=3286036&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F3099e87c-1cf6-11df-aef7-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Competition produces better managed hospitals which, in turn, produce better outcomes for patients, according to new research from the Centre for Economic Performance... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3286036</comments>
            <pubDate>Fri, 19 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3286036</guid>        </item>
        <item>
            <title>AstraZeneca signs arthritis drug deal</title>
            <link>http://www.medworm.com/index.php?rid=3278144&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F0cb322f8-1ae8-11df-88fa-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Anglo-Swedish pharmaceutical group is to pay at least $100m to Rigel Pharmaceuticals to test and commercialise its experimental rheumatoid arthritis drug as part of its new strategy (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3278144</comments>
            <pubDate>Tue, 16 Feb 2010 18:35:31 +0100</pubDate>
            <guid isPermaLink="false">3278144</guid>        </item>
        <item>
            <title>Scientists discover the secret of ageing</title>
            <link>http://www.medworm.com/index.php?rid=3274540&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F436a39a0-1a6e-11df-a2e3-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Breakthrough in cell research offers hope of better drugs for age-related illnesses such as diabetes and heart disease, but no elixir of eternal life is expected in the foreseeable future. (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3274540</comments>
            <pubDate>Mon, 15 Feb 2010 23:00:38 +0100</pubDate>
            <guid isPermaLink="false">3274540</guid>        </item>
        <item>
            <title>Doctors attack business involvement in NHS</title>
            <link>http://www.medworm.com/index.php?rid=3268589&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F94963336-17f0-11df-91d2-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The British Medical Association has launched a costly pre-election campaign attacking the way &quot;big businesses are taking money out of the NHS&quot; and putting &quot;profits before patients&quot; (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3268589</comments>
            <pubDate>Fri, 12 Feb 2010 16:31:55 +0100</pubDate>
            <guid isPermaLink="false">3268589</guid>        </item>
        <item>
            <title>Efforts stepped up on hospital debts</title>
            <link>http://www.medworm.com/index.php?rid=3265107&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F1878d9d2-1775-11df-87f6-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Drug and medical device companies are bracing themselves for a revised proposal from the Greek government as the authorities attempt to pay off nearly €7bn in... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3265107</comments>
            <pubDate>Fri, 12 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3265107</guid>        </item>
        <item>
            <title>Smith &amp; Nephew beats expectations</title>
            <link>http://www.medworm.com/index.php?rid=3265104&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff29074aa-1729-11df-94f6-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Full-year sales growth at Smith &amp; Nephew slows, but the maker of artificial hips and knee joints posts a stronger-than-expected fourth quarter in its smaller divisions, helping to push shares to their highest level in 18 months (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3265104</comments>
            <pubDate>Fri, 12 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3265104</guid>        </item>
        <item>
            <title>Savings 'do not have to hit NHS care quality'</title>
            <link>http://www.medworm.com/index.php?rid=3265105&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd9442704-173c-11df-94f6-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Efficiency gains of up to £20bn could be made by applying existing knowledge more widely and without affecting the service received by patients, a consultant argues (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3265105</comments>
            <pubDate>Thu, 11 Feb 2010 23:25:23 +0100</pubDate>
            <guid isPermaLink="false">3265105</guid>        </item>
        <item>
            <title>Tax breaks on health plans will be needed</title>
            <link>http://www.medworm.com/index.php?rid=3265106&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F0e2a0f6a-173d-11df-94f6-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Tax breaks for private health care and new charges for NHS services will have to be considered by the next government, the head of Britain's biggest private hospital group said (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3265106</comments>
            <pubDate>Thu, 11 Feb 2010 19:29:24 +0100</pubDate>
            <guid isPermaLink="false">3265106</guid>        </item>
        <item>
            <title>Authorities owe €7bn in hospital debts</title>
            <link>http://www.medworm.com/index.php?rid=3261074&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd4713708-1665-11df-bf44-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Drug and medical device companies are bracing for a revised proposal from the Greek government as the authorities attempt to pay off nearly €7bn in outstanding hospital debts (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3261074</comments>
            <pubDate>Wed, 10 Feb 2010 23:29:23 +0100</pubDate>
            <guid isPermaLink="false">3261074</guid>        </item>
        <item>
            <title>Elan expects first operating profit in years</title>
            <link>http://www.medworm.com/index.php?rid=3261075&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F03ca2b5c-161d-11df-8d0f-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Increased demand for its multiple sclerosis drug and a tie-up with Johnson &amp; Johnson has helped the Irish pharmaceutical group to trim losses and forecast a better year in 2010 (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3261075</comments>
            <pubDate>Wed, 10 Feb 2010 16:18:52 +0100</pubDate>
            <guid isPermaLink="false">3261075</guid>        </item>
        <item>
            <title>Sanofi gears up for $1bn deal with Merck</title>
            <link>http://www.medworm.com/index.php?rid=3261076&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2a7feca2-1639-11df-8d0f-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The French phamaceutical group indicated that it was set to create one of the world's largest animal health companies through a joint venture with Merck of the US (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3261076</comments>
            <pubDate>Wed, 10 Feb 2010 12:55:20 +0100</pubDate>
            <guid isPermaLink="false">3261076</guid>        </item>
        <item>
            <title>ReNeuron approved for stem cell trial</title>
            <link>http://www.medworm.com/index.php?rid=3257018&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fee44e6aa-15b3-11df-ad7e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK Gene Therapy Advisory Committee has given approval for the company to begin the world's first human test of stem cell therapy with a dozen stroke patients (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3257018</comments>
            <pubDate>Wed, 10 Feb 2010 00:06:54 +0100</pubDate>
            <guid isPermaLink="false">3257018</guid>        </item>
        <item>
            <title>UK court overturns GSK patent for lupus drug</title>
            <link>http://www.medworm.com/index.php?rid=3257019&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F613e6410-15a0-11df-ad7e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The court of appeal upheld a plea by Eli Lilly challenging patents filed on the sequence of the protein neutrokine-alpha identified by scanning the human genome for potential applications (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3257019</comments>
            <pubDate>Tue, 09 Feb 2010 23:08:55 +0100</pubDate>
            <guid isPermaLink="false">3257019</guid>        </item>
        <item>
            <title>Alliance to buy Cambridge Laboratories</title>
            <link>http://www.medworm.com/index.php?rid=3252829&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fae41e3ce-149a-11df-9ea1-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The speciality drug company is to buy the bulk of Cambridge Laboratories in a deal valued at between £14m and £16m that will be part-funded with a share placing by Alliance (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3252829</comments>
            <pubDate>Mon, 08 Feb 2010 22:32:16 +0100</pubDate>
            <guid isPermaLink="false">3252829</guid>        </item>
        <item>
            <title>Montagu set to float BSN Medical</title>
            <link>http://www.medworm.com/index.php?rid=3249605&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fecfc80e2-1413-11df-8847-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The German bandages maker has become the latest private equity-owned company to prepare for an initial public offering (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3249605</comments>
            <pubDate>Mon, 08 Feb 2010 01:44:25 +0100</pubDate>
            <guid isPermaLink="false">3249605</guid>        </item>
        <item>
            <title>Pfizer launches e-payment system</title>
            <link>http://www.medworm.com/index.php?rid=3249606&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F503e764c-1414-11df-8847-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The scheme will link the pharmaceutical group directly with patients in many of the world's fastest-growing economies, a move that could boost use of its high-priced medicines (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3249606</comments>
            <pubDate>Mon, 08 Feb 2010 01:43:33 +0100</pubDate>
            <guid isPermaLink="false">3249606</guid>        </item>
        <item>
            <title>GSK shifts away from antidepressants</title>
            <link>http://www.medworm.com/index.php?rid=3241959&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F103e87d2-11c4-11df-9d45-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>GlaxoSmithKline is to stop researching antidepressant medicines as part of a shake up in research and development designed to strengthen productivity (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3241959</comments>
            <pubDate>Thu, 04 Feb 2010 20:47:22 +0100</pubDate>
            <guid isPermaLink="false">3241959</guid>        </item>
        <item>
            <title>GSK sales jump in emerging markets</title>
            <link>http://www.medworm.com/index.php?rid=3237936&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd104345c-1184-11df-9195-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Surging sales in emerging markets as well as greater demand for vaccines have helped GlaxoSmithKline to compensate for declining revenues in the US (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237936</comments>
            <pubDate>Thu, 04 Feb 2010 14:25:42 +0100</pubDate>
            <guid isPermaLink="false">3237936</guid>        </item>
        <item>
            <title>German workers strike over pay</title>
            <link>http://www.medworm.com/index.php?rid=3237939&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff066dd24-1146-11df-a6d6-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Public sector workers launched a week of token &quot;warning strikes&quot; across Germany yesterday in pursuit of a 5 per cent pay claim, in spite of a warning from local... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237939</comments>
            <pubDate>Thu, 04 Feb 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3237939</guid>        </item>
        <item>
            <title>Expiry of patents cost Pfizer</title>
            <link>http://www.medworm.com/index.php?rid=3237937&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7c92f896-10e8-11df-9a9e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The world's largest pharmaceutical group posts fourth-quarter profits up sharply to $767m but has lowered its guidance for 2012 after the patents on its best-selling drug expires (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237937</comments>
            <pubDate>Wed, 03 Feb 2010 23:58:36 +0100</pubDate>
            <guid isPermaLink="false">3237937</guid>        </item>
        <item>
            <title>Coma victim 'talks' via brain scanner</title>
            <link>http://www.medworm.com/index.php?rid=3237938&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F365d806c-10ed-11df-9a9e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A road accident victim, presumed by his doctors to be in a persistent vegetative state, has answered simple questions by using thought alone, neuroscientists report (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3237938</comments>
            <pubDate>Wed, 03 Feb 2010 22:18:25 +0100</pubDate>
            <guid isPermaLink="false">3237938</guid>        </item>
        <item>
            <title>Genentech buy-out deal weighs on Roche</title>
            <link>http://www.medworm.com/index.php?rid=3233912&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F93bae8e4-1093-11df-975e-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Full-year net profits at the Swiss pharmaceutical group fall 22% as it is hit by one-off costs relating to the $47bn acquisition of minority shares in US subsidiary Genentech (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3233912</comments>
            <pubDate>Wed, 03 Feb 2010 07:46:22 +0100</pubDate>
            <guid isPermaLink="false">3233912</guid>        </item>
        <item>
            <title>Lancet retracts MMR link to autism</title>
            <link>http://www.medworm.com/index.php?rid=3233913&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7d74f256-103d-11df-841f-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The research paper that triggered claims linking autism to the vaccine for measles, mumps and rubella has been retracted by the Lancet, the medical journal that published it more than a decade ago (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3233913</comments>
            <pubDate>Tue, 02 Feb 2010 21:03:16 +0100</pubDate>
            <guid isPermaLink="false">3233913</guid>        </item>
        <item>
            <title>Big drug groups urged to buy in test products</title>
            <link>http://www.medworm.com/index.php?rid=3226225&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2ed73272-0eb6-11df-bd79-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Shift from developing drugs in-house to purchasing experimental products from smaller rivals would lift success rates, lower costs and triple returns (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3226225</comments>
            <pubDate>Sun, 31 Jan 2010 22:46:04 +0100</pubDate>
            <guid isPermaLink="false">3226225</guid>        </item>
        <item>
            <title>GSK to announce more than 3,000 job cuts</title>
            <link>http://www.medworm.com/index.php?rid=3226226&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd0b8b1a2-0e83-11df-bd79-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Fall in GSK's headcount in its western pharmaceutical operations to be offset by fresh recruitment in emerging markets and non-pharmaceutical operations (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3226226</comments>
            <pubDate>Sun, 31 Jan 2010 22:36:54 +0100</pubDate>
            <guid isPermaLink="false">3226226</guid>        </item>
        <item>
            <title>Gates gives $10bn to fight disease</title>
            <link>http://www.medworm.com/index.php?rid=3224240&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2912426e-0d3f-11df-af79-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Bill Gates, the philanthropist and co-founder of Microsoft, is to give $10bn (€7bn, ?6bn) over the next 10 years for the development and use of vaccines to fight... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3224240</comments>
            <pubDate>Sat, 30 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3224240</guid>        </item>
        <item>
            <title>Alliance Boots axes final-salary pension plan</title>
            <link>http://www.medworm.com/index.php?rid=3224241&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F69c3d686-0d0f-11df-a2dc-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK-based health and beauty retailer is to become the latest company to close its final-salary pension scheme to existing members (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3224241</comments>
            <pubDate>Fri, 29 Jan 2010 20:10:34 +0100</pubDate>
            <guid isPermaLink="false">3224241</guid>        </item>
        <item>
            <title>Seroquel pain</title>
            <link>http://www.medworm.com/index.php?rid=3218751&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd1a66f34-0c74-11df-a941-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>AstraZeneca faces costs of up to $1.2bn from the escalating number of legal cases brought by patients and regulators suing it over alleged improper marketing and side... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218751</comments>
            <pubDate>Fri, 29 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218751</guid>        </item>
        <item>
            <title>BMA alert on plan to scrap GP boundaries</title>
            <link>http://www.medworm.com/index.php?rid=3218750&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F13ac30f8-0c75-11df-a941-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The British Medical Association has fired a broadside at government plans to give patients a completely free choice of family doctor, warning that the proposals could... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218750</comments>
            <pubDate>Fri, 29 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218750</guid>        </item>
        <item>
            <title>Blueprint for the next blockbuster drug</title>
            <link>http://www.medworm.com/index.php?rid=3218748&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fa0cee404-0c47-11df-8b81-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The head of AstraZeneca has outlined a tightly focused research and development agenda that he hopes will yield the next blockbuster drug (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218748</comments>
            <pubDate>Fri, 29 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218748</guid>        </item>
        <item>
            <title>MMR-scare doctor found in breach of duty</title>
            <link>http://www.medworm.com/index.php?rid=3218749&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc526c4c4-0c2a-11df-8b81-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Andrew Wakefield, the doctor behind fiercely disputed claims that the MMR – measles, mumps and rubella – vaccine causes autism, has been found in breach of his duties by his professional body (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218749</comments>
            <pubDate>Thu, 28 Jan 2010 19:56:37 +0100</pubDate>
            <guid isPermaLink="false">3218749</guid>        </item>
        <item>
            <title>Large contracts boost System C earnings</title>
            <link>http://www.medworm.com/index.php?rid=3214710&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff77d0d92-0b4f-11df-9109-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Revenues at the healthcare software provider rose by 77% for the six months to November due to large contracts to clear work backlog for the delayed National Programme for Health (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3214710</comments>
            <pubDate>Thu, 28 Jan 2010 02:27:04 +0100</pubDate>
            <guid isPermaLink="false">3214710</guid>        </item>
        <item>
            <title>Weight gain played down in drugs ad</title>
            <link>http://www.medworm.com/index.php?rid=3214711&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F960ec1ba-0b70-11df-8232-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>AstraZeneca, the Anglo-Swedish pharmaceutical group, played down in a UK advertisement the risk that patients taking its anti-psychotic medicine Seroquel would put on weight, a BBC radio programme will say (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3214711</comments>
            <pubDate>Wed, 27 Jan 2010 18:26:47 +0100</pubDate>
            <guid isPermaLink="false">3214711</guid>        </item>
        <item>
            <title>Vasella to drop CEO role at Novartis</title>
            <link>http://www.medworm.com/index.php?rid=3210435&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F4ecc8732-0a4a-11df-ab4a-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Daniel Vasella is to give up his role as chief executive of the Swiss pharmaceuticals group to concentrate on the chairmanship (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210435</comments>
            <pubDate>Tue, 26 Jan 2010 19:18:18 +0100</pubDate>
            <guid isPermaLink="false">3210435</guid>        </item>
        <item>
            <title>Novartis in stealthy pursuit of change</title>
            <link>http://www.medworm.com/index.php?rid=3210436&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc39af5fc-0aa5-11df-b35f-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The changes announced by Novartis reflect long-standing shareholder pressure for change at the Swiss company to improve performance, broader corporate governance trends Europe-wide and intensifying peer pressure (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210436</comments>
            <pubDate>Tue, 26 Jan 2010 18:25:25 +0100</pubDate>
            <guid isPermaLink="false">3210436</guid>        </item>
        <item>
            <title>Vasella steps down as Novartis chief</title>
            <link>http://www.medworm.com/index.php?rid=3206954&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F4ecc8732-0a4a-11df-ab4a-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Daniel Vasella is to give up his role as chief executive of the Swiss pharmaceuticals group to concentrate on the chairmanship (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3206954</comments>
            <pubDate>Tue, 26 Jan 2010 07:39:51 +0100</pubDate>
            <guid isPermaLink="false">3206954</guid>        </item>
        <item>
            <title>US nurse shortage boost for locum supplier</title>
            <link>http://www.medworm.com/index.php?rid=3206955&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F296fbf7a-09d4-11df-8b23-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Healthcare Locums, the UK's largest supplier of short-term healthcare professionals, is poised to benefit from rising demand for nurses in the US should Congress pass President Obama's health reform bill (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3206955</comments>
            <pubDate>Mon, 25 Jan 2010 17:20:43 +0100</pubDate>
            <guid isPermaLink="false">3206955</guid>        </item>
        <item>
            <title>Spending squeeze to hurt PFI hospitals the most</title>
            <link>http://www.medworm.com/index.php?rid=3199491&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F589828ee-07bf-11df-915f-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>NHS hospitals built under the private finance initiative will have a much tougher time making the productivity and efficiency gains that are needed as public spending... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199491</comments>
            <pubDate>Sat, 23 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199491</guid>        </item>
        <item>
            <title>Flexible pricing policy pays off in diverse drugs market</title>
            <link>http://www.medworm.com/index.php?rid=3195976&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fdf6a9832-06f4-11df-b058-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Abbas Hussain may be based in London but he has returned to his roots since he was headhunted to join GlaxoSmithKline in 2008 to take charge of emerging markets... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3195976</comments>
            <pubDate>Fri, 22 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3195976</guid>        </item>
        <item>
            <title>Alcon dismisses Novartis offer</title>
            <link>http://www.medworm.com/index.php?rid=3191579&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc836b44c-062d-11df-8c97-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The independent directors of Alcon, the US-based eyecare company, yesterday dismissed as &quot;grossly inadequate&quot; Novartis' offer to minority shareholders for the full... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3191579</comments>
            <pubDate>Thu, 21 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3191579</guid>        </item>
        <item>
            <title>GSK gives price pledge on malaria vaccine</title>
            <link>http://www.medworm.com/index.php?rid=3191577&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F03fbd68a-05ff-11df-8c97-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK-based pharmaceutical group vows to price its experimental malaria vaccine at just above cost, in an effort to ensure funding for its widespread use (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3191577</comments>
            <pubDate>Thu, 21 Jan 2010 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3191577</guid>        </item>
        <item>
            <title>Two MS drugs soon to be offered</title>
            <link>http://www.medworm.com/index.php?rid=3191578&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fab9838c2-0616-11df-8c97-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Two competing pills to treat multiple sclerosis, cladribine and fingolimod, could reach the market this year or next after large clinical trial results showed the efficacy of the two treatments (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3191578</comments>
            <pubDate>Thu, 21 Jan 2010 00:25:09 +0100</pubDate>
            <guid isPermaLink="false">3191578</guid>        </item>
        <item>
            <title>England outperforms rest of UK on health</title>
            <link>http://www.medworm.com/index.php?rid=3187516&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F25e18bce-052c-11df-a85e-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Labour's health policies in England have delivered better results than the co-operative approach used in Scotland, Wales and Northern Ireland (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3187516</comments>
            <pubDate>Wed, 20 Jan 2010 00:08:53 +0100</pubDate>
            <guid isPermaLink="false">3187516</guid>        </item>
        <item>
            <title>Ontario Teachers to buy Acorn Care</title>
            <link>http://www.medworm.com/index.php?rid=3184162&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F9e33ee10-045e-11df-8603-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Direct investment from pension fund in £150m care provider breaks private equity's grip on the buy-out market (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3184162</comments>
            <pubDate>Mon, 18 Jan 2010 23:06:14 +0100</pubDate>
            <guid isPermaLink="false">3184162</guid>        </item>
        <item>
            <title>GHG set for parade of flotation advisers</title>
            <link>http://www.medworm.com/index.php?rid=3181152&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fb2ab3c5c-038e-11df-a601-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The private equity backers of General Healthcare Group will be choosing investment banking advisers for the planned £1bn initial public offering of the UK hospital operator (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3181152</comments>
            <pubDate>Mon, 18 Jan 2010 01:23:20 +0100</pubDate>
            <guid isPermaLink="false">3181152</guid>        </item>
        <item>
            <title>GSK braced for low sales of flu drug</title>
            <link>http://www.medworm.com/index.php?rid=3181151&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fced13c7c-0372-11df-a601-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK based pharmaceutical company is bracing itself for sales on its pandemic flu vaccines to be as low as three-quarters of forecast levels of £2bn, as a growing number of European countries renege on existing contracts (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3181151</comments>
            <pubDate>Mon, 18 Jan 2010 01:23:20 +0100</pubDate>
            <guid isPermaLink="false">3181151</guid>        </item>
        <item>
            <title>Priory Group eyes IPO</title>
            <link>http://www.medworm.com/index.php?rid=3181153&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fa98bb132-038a-11df-a601-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Priory Group, the psychiatric hospital chain, has become the latest company to announce that it is planning to float on the stock market (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3181153</comments>
            <pubDate>Sun, 17 Jan 2010 22:57:39 +0100</pubDate>
            <guid isPermaLink="false">3181153</guid>        </item>
        <item>
            <title>Novartis spurs investor fight for equality</title>
            <link>http://www.medworm.com/index.php?rid=3181154&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F582e0722-038a-11df-a601-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Thorny issue of offering two groups of investors two different prices for the same stock during takeovers raises its head at Novartis (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3181154</comments>
            <pubDate>Sun, 17 Jan 2010 22:57:02 +0100</pubDate>
            <guid isPermaLink="false">3181154</guid>        </item>
        <item>
            <title>J&amp;J issues recall of best-selling drugs</title>
            <link>http://www.medworm.com/index.php?rid=3177786&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fdf7e5154-0214-11df-8b56-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The drugmaker issued a recall of millions of bottles of its best-selling over-the-counter drugs, including Tylenol and Motrin, after being urged by the Food and Drug Administration to speed up its investigation into their safety (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3177786</comments>
            <pubDate>Fri, 15 Jan 2010 21:05:43 +0100</pubDate>
            <guid isPermaLink="false">3177786</guid>        </item>
        <item>
            <title>Lombard Medical in £13m fundraising</title>
            <link>http://www.medworm.com/index.php?rid=3169602&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F47738baa-005b-11df-b50b-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Aim-quoted medical device company will launch a placing and subscription offer in order to avoid running short of working capital (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3169602</comments>
            <pubDate>Wed, 13 Jan 2010 23:10:49 +0100</pubDate>
            <guid isPermaLink="false">3169602</guid>        </item>
        <item>
            <title>UK lacks world-class hospitals, says regulator</title>
            <link>http://www.medworm.com/index.php?rid=3161993&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F8dd755f2-fee6-11de-a677-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Britain lacks any world-class hospitals because the culture of the National Health Service is still too much one of central direction and control, says William Moyes (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161993</comments>
            <pubDate>Mon, 11 Jan 2010 23:49:30 +0100</pubDate>
            <guid isPermaLink="false">3161993</guid>        </item>
        <item>
            <title>Alcon to line up Novartis bid defence</title>
            <link>http://www.medworm.com/index.php?rid=3161992&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F94eac032-fedb-11de-a677-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Independent directors of US eye care group to discuss valuation and tactics with banking and legal advisers in New York ahead of formal public response to Novartis (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161992</comments>
            <pubDate>Mon, 11 Jan 2010 23:49:30 +0100</pubDate>
            <guid isPermaLink="false">3161992</guid>        </item>
        <item>
            <title>Fear over quality of a centralised NHS</title>
            <link>http://www.medworm.com/index.php?rid=3161994&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F587c77ac-fee6-11de-a677-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>If the next government centralises control of the NHS, it risks damaging patient care, warns the outgoing chairman of Monitor, the independent regulator (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161994</comments>
            <pubDate>Mon, 11 Jan 2010 23:31:06 +0100</pubDate>
            <guid isPermaLink="false">3161994</guid>        </item>
        <item>
            <title>UK push for greater use of generic drugs</title>
            <link>http://www.medworm.com/index.php?rid=3161995&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7b6d09bc-ff03-11de-a677-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Measures to increase the use of generic medicines in place of more expensive branded drugs are being put forward by the government as it seeks to save up to £50m a year (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161995</comments>
            <pubDate>Mon, 11 Jan 2010 23:01:20 +0100</pubDate>
            <guid isPermaLink="false">3161995</guid>        </item>
        <item>
            <title>Tax amnesty targets medical professionals</title>
            <link>http://www.medworm.com/index.php?rid=3155066&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F6f464694-fc8d-11de-bc51-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A partial amnesty for doctors and dentists who have failed to declare income to the Revenue will be launched on Monday, in the opening salvo of a new campaign (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3155066</comments>
            <pubDate>Fri, 08 Jan 2010 23:33:50 +0100</pubDate>
            <guid isPermaLink="false">3155066</guid>        </item>
        <item>
            <title>Proximagen buys Minster for £4.3m</title>
            <link>http://www.medworm.com/index.php?rid=3140951&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F59a1a636-f980-11de-8085-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The specialist maker of drugs for treating neuro-degenerative diseases is to make its second acquisition since raising £50m on Aim last summer (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3140951</comments>
            <pubDate>Mon, 04 Jan 2010 23:12:02 +0100</pubDate>
            <guid isPermaLink="false">3140951</guid>        </item>
        <item>
            <title>Novartis seeks to complete Alcon buy-out</title>
            <link>http://www.medworm.com/index.php?rid=3138359&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc8c0aee0-f90d-11de-80dc-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Swiss drugs group offers to buy out minority shareholders in the US eyecare company, and will buy Nestlé's remaining stake, for a total of nearly $50bn (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3138359</comments>
            <pubDate>Mon, 04 Jan 2010 09:12:11 +0100</pubDate>
            <guid isPermaLink="false">3138359</guid>        </item>
        <item>
            <title>Innovations buoy diagnostics sector</title>
            <link>http://www.medworm.com/index.php?rid=3138360&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F37709336-f897-11de-beb8-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Rapid, on-the-spot tests that can be administered in GP surgeries or in a patient's home are replacing cumbersome laboratory procedures (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3138360</comments>
            <pubDate>Sun, 03 Jan 2010 22:40:04 +0100</pubDate>
            <guid isPermaLink="false">3138360</guid>        </item>
        <item>
            <title>Charge drunks for detox, say Tory advisers</title>
            <link>http://www.medworm.com/index.php?rid=3131939&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff0a94c28-f57f-11de-90ab-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Policy Exchange call for radical measures to tackle alcohol misuse may embarrass the Conservative leader, who has gone to great lengths to try to reassure voters that a Tory government would not undermine public services (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3131939</comments>
            <pubDate>Thu, 31 Dec 2009 00:01:11 +0100</pubDate>
            <guid isPermaLink="false">3131939</guid>        </item>
        <item>
            <title>CustomVis expects new device to boost sales</title>
            <link>http://www.medworm.com/index.php?rid=3131940&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fcf9a70c0-f55c-11de-90ab-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The laser vision correction specialist is in negotiations to sell significant numbers of its new portable digital camera for photographing retinas and expects sales to commence in the third quarter of 2010 (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3131940</comments>
            <pubDate>Wed, 30 Dec 2009 23:39:13 +0100</pubDate>
            <guid isPermaLink="false">3131940</guid>        </item>
        <item>
            <title>Tough approval regime drives studies abroad</title>
            <link>http://www.medworm.com/index.php?rid=3131942&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F25234c48-f570-11de-90ab-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK has historically held a position that far outstrips the size of its economy or population. Yet many see its status ever more under threat, as developing countries in particular claim a growing share of clinical trials around the world (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3131942</comments>
            <pubDate>Wed, 30 Dec 2009 23:30:28 +0100</pubDate>
            <guid isPermaLink="false">3131942</guid>        </item>
        <item>
            <title>Clinical trials of drugs fall in UK</title>
            <link>http://www.medworm.com/index.php?rid=3131941&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2b66d8ae-f570-11de-90ab-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Bureaucracy, low recruitment rates and the slow uptake of new drugs are pushing pharmaceutical companies to undertake more research in other countries in Europe, North America and low-cost developing nations (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3131941</comments>
            <pubDate>Wed, 30 Dec 2009 23:30:28 +0100</pubDate>
            <guid isPermaLink="false">3131941</guid>        </item>
        <item>
            <title>Prevention better than promise of a cure</title>
            <link>http://www.medworm.com/index.php?rid=3131943&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F61045cb4-f3dd-11de-ac55-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>While new drugs and vaccines offer progress, psychological and social techniques to improve compliance with existing therapies, and to change human behaviour to aid prevention, are still among the greatest potential benefits in the years ahead (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3131943</comments>
            <pubDate>Wed, 30 Dec 2009 17:32:42 +0100</pubDate>
            <guid isPermaLink="false">3131943</guid>        </item>
        <item>
            <title>Drugmaker has unique model to compete</title>
            <link>http://www.medworm.com/index.php?rid=3127996&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd377f85c-f4a8-11de-9cba-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Hikma Pharmaceuticals has created a business from selling both generic medicines and those under patent to others, helping the Jordan-based group reach annual turnover of $581m (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127996</comments>
            <pubDate>Tue, 29 Dec 2009 20:26:13 +0100</pubDate>
            <guid isPermaLink="false">3127996</guid>        </item>
        <item>
            <title>Ranbaxy retreats from China venture</title>
            <link>http://www.medworm.com/index.php?rid=3127995&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F70964eae-f49f-11de-9cba-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>India's largest drugmaker has taken steps to consolidate its manufacturing operations by quitting one of the highest-profile Indian investments in China (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127995</comments>
            <pubDate>Tue, 29 Dec 2009 20:26:13 +0100</pubDate>
            <guid isPermaLink="false">3127995</guid>        </item>
        <item>
            <title>UK groups look abroad to fight superbugs</title>
            <link>http://www.medworm.com/index.php?rid=3125819&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff989ee86-f405-11de-ac55-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>British companies developing products against hospital-acquired infections are complaining of few opportunities in domestic markets, and focusing their sales efforts overseas (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3125819</comments>
            <pubDate>Tue, 29 Dec 2009 00:54:07 +0100</pubDate>
            <guid isPermaLink="false">3125819</guid>        </item>
        <item>
            <title>Medicines discount deal for Caterpillar staff</title>
            <link>http://www.medworm.com/index.php?rid=3123927&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F6abf5a80-f30e-11de-a888-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A discount medicines health plan for workers at Caterpillar will steer them towards pharmacies operated by two leading US retail chains (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3123927</comments>
            <pubDate>Sun, 27 Dec 2009 19:13:05 +0100</pubDate>
            <guid isPermaLink="false">3123927</guid>        </item>
        <item>
            <title>AZ and Forest tie up to buy Novexel</title>
            <link>http://www.medworm.com/index.php?rid=3117349&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F4626d016-f018-11de-833d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK and US pharmaceutical companies are to pay up to $425m to buy Novexel, a private France-based drug company specialising in the development of antibiotics (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3117349</comments>
            <pubDate>Wed, 23 Dec 2009 23:58:47 +0100</pubDate>
            <guid isPermaLink="false">3117349</guid>        </item>
        <item>
            <title>Allied Healthcare makes offer for Supporta</title>
            <link>http://www.medworm.com/index.php?rid=3117350&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F9ec7dd18-efe7-11de-833d-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The home care and healthcare staff services company has submitted an indicative cash offer for the domiciliary care provider which competes with the £27.2m bid recommended by Supporta's board (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3117350</comments>
            <pubDate>Wed, 23 Dec 2009 23:25:45 +0100</pubDate>
            <guid isPermaLink="false">3117350</guid>        </item>
        <item>
            <title>Romac urges Supporta to re-think Mears offer</title>
            <link>http://www.medworm.com/index.php?rid=3113351&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F32825646-ef1b-11de-86c4-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The investment company has asked the domiciliary care provider's board to consider a cash offer for the company that is higher than the recommended all-share bid made by Mears (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3113351</comments>
            <pubDate>Wed, 23 Dec 2009 00:17:33 +0100</pubDate>
            <guid isPermaLink="false">3113351</guid>        </item>
        <item>
            <title>Buy-out groups eye healthcare tonic</title>
            <link>http://www.medworm.com/index.php?rid=3109813&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7efa9254-ee5d-11de-944c-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Several providers of healthcare services are about to be acquired as private equity groups expect to submit bids to UK's operators of care homes (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3109813</comments>
            <pubDate>Mon, 21 Dec 2009 22:24:31 +0100</pubDate>
            <guid isPermaLink="false">3109813</guid>        </item>
        <item>
            <title>Sanofi-Aventis to buy Chattem for $1.9bn</title>
            <link>http://www.medworm.com/index.php?rid=3109814&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F7e8991f6-ee3c-11de-a274-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>French drugmaker announces it has agreed to acquire the US consumer healthcare company in a deal that will give it a stronger footing in the American market (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3109814</comments>
            <pubDate>Mon, 21 Dec 2009 18:57:52 +0100</pubDate>
            <guid isPermaLink="false">3109814</guid>        </item>
        <item>
            <title>Cancer drug blow for Ark Therapeutics</title>
            <link>http://www.medworm.com/index.php?rid=3103481&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F00f1a9fc-ebdc-11de-930c-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Shares in the company lost 44% at stage point in the day's trading amid news that its treatment for brain cancer was rejected by European medicines regulators (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3103481</comments>
            <pubDate>Sat, 19 Dec 2009 04:02:40 +0100</pubDate>
            <guid isPermaLink="false">3103481</guid>        </item>
        <item>
            <title>Danaher to take over Genetix</title>
            <link>http://www.medworm.com/index.php?rid=3103482&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F4921cba0-ec07-11de-8070-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The 85p a share all-cash offer by the US diversified manufacturer for the biotechnology group values the Hampshire-based company at more than £63m (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3103482</comments>
            <pubDate>Sat, 19 Dec 2009 00:58:10 +0100</pubDate>
            <guid isPermaLink="false">3103482</guid>        </item>
        <item>
            <title>Latest 'Final Fantasy' may be Sony PS3's final chance</title>
            <link>http://www.medworm.com/index.php?rid=3098694&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fb8935f18-eb75-11de-bc99-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Can active time battles, characters called &quot;Lightning&quot; and &quot;Snow&quot;, and a convoluted story set in the fantasy world of Pulse turn round Sony's PlayStation 3? With the... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3098694</comments>
            <pubDate>Fri, 18 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3098694</guid>        </item>
        <item>
            <title>Adults embellish exercise claims</title>
            <link>http://www.medworm.com/index.php?rid=3098693&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F3656dea8-eb3e-11de-bc99-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>We lie about how fit we are. The only good news is that those who claim to do more exercise are in fact fitter – even if they are lying – than those who admit to being couch potatoes (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3098693</comments>
            <pubDate>Fri, 18 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3098693</guid>        </item>
        <item>
            <title>Care UK receives improved offer</title>
            <link>http://www.medworm.com/index.php?rid=3094640&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fe8e9276a-ea94-11de-a9f5-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Bridgepoint, the private equity group, has sweetened its bid for the care home operator , valuing it at between £275m and £300m. (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094640</comments>
            <pubDate>Wed, 16 Dec 2009 23:25:06 +0100</pubDate>
            <guid isPermaLink="false">3094640</guid>        </item>
        <item>
            <title>Cancer 'maps' pave way for tailored drugs</title>
            <link>http://www.medworm.com/index.php?rid=3094638&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fa06f6e8e-ea7d-11de-a9f5-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The first complete cancer genomes, or genetic maps, have been deciphered by UK scientists, paving the way for treatments tailored to individual patients (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094638</comments>
            <pubDate>Wed, 16 Dec 2009 23:25:06 +0100</pubDate>
            <guid isPermaLink="false">3094638</guid>        </item>
        <item>
            <title>US vows science-based approach in Aids fight</title>
            <link>http://www.medworm.com/index.php?rid=3094639&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F6e5c3754-ea6b-11de-a9f5-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The new head of Washington's programme to tackle HIV outlined a fresh five-year strategy for Pepfar, saying future programmes to prevent HIV infection would be those supported by the best scientific evidence. (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094639</comments>
            <pubDate>Wed, 16 Dec 2009 17:58:08 +0100</pubDate>
            <guid isPermaLink="false">3094639</guid>        </item>
        <item>
            <title>Sanofi chairman set to cede control</title>
            <link>http://www.medworm.com/index.php?rid=3091227&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fcdd68e5a-e99e-11de-9f1f-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Jean-Francois Dehecq, charismatic chairman of Sanofi-Aventis is set to hand over control next year to Serge Weinberg, the businessman and banker (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3091227</comments>
            <pubDate>Wed, 16 Dec 2009 10:25:43 +0100</pubDate>
            <guid isPermaLink="false">3091227</guid>        </item>
        <item>
            <title>HIV pool adds to pressure on drug groups</title>
            <link>http://www.medworm.com/index.php?rid=3091228&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F561186aa-e998-11de-9f1f-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Nine pharmaceutical companies face pressure to ease control over HIV medicines following the establishment of an international mechanism designed to increase treatment access in the developing world (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3091228</comments>
            <pubDate>Tue, 15 Dec 2009 17:12:36 +0100</pubDate>
            <guid isPermaLink="false">3091228</guid>        </item>
        <item>
            <title>GSK's $15m fees data go online</title>
            <link>http://www.medworm.com/index.php?rid=3087619&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fde203e0e-e8ff-11de-a756-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>GlaxoSmithKlinepaid close to $15m (£9m) in speaking and consulting fees to US doctors in the second quarter of this year, revealing the scale of
commercial links to influential prescribers (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3087619</comments>
            <pubDate>Mon, 14 Dec 2009 22:37:13 +0100</pubDate>
            <guid isPermaLink="false">3087619</guid>        </item>
        <item>
            <title>'Ideologues' fail to understand principles of NHS reform</title>
            <link>http://www.medworm.com/index.php?rid=3081387&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F9ab691f6-e6be-11de-98b1-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Since Tony Blair left office, tracking Labour's fluctuating attitude to the role of choice and competition in improving the NHS has taken the skills of a... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3081387</comments>
            <pubDate>Sat, 12 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3081387</guid>        </item>
        <item>
            <title>Warning NHS pay restraint crucial</title>
            <link>http://www.medworm.com/index.php?rid=3081385&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F6fba7dfe-e683-11de-98b1-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The public needs to accept dramatic changes in how care is provided, with much less care in hospital, if the NHS is to meet the challenge of altered circumstances, says its chief executive (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3081385</comments>
            <pubDate>Sat, 12 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3081385</guid>        </item>
        <item>
            <title>Pharma groups plan anti-diarrhoea vaccine</title>
            <link>http://www.medworm.com/index.php?rid=3081386&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ffd3b045e-e666-11de-bcbe-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Move marks a fresh sign of interest by pharma companies in vaccines as a way to diversify away from drugs and a step away from using needles (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3081386</comments>
            <pubDate>Fri, 11 Dec 2009 22:53:48 +0100</pubDate>
            <guid isPermaLink="false">3081386</guid>        </item>
        <item>
            <title>GSK threatens to shift investment from UK</title>
            <link>http://www.medworm.com/index.php?rid=3077669&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F2be18cd4-e5ad-11de-b5d7-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>UK-based drugs group may shift a planned £300m investment to develop and manufacture its next generation of medicines offshore unless the government rapidly implements new tax incentives (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077669</comments>
            <pubDate>Thu, 10 Dec 2009 23:18:33 +0100</pubDate>
            <guid isPermaLink="false">3077669</guid>        </item>
        <item>
            <title>UK doctors enjoy best pay deals</title>
            <link>http://www.medworm.com/index.php?rid=3073723&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ffe5c2380-e52c-11de-9a25-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>British GPs are paid more and have received higher rises in recent years than counterparts anywhere else in the industrialised world, according to data released by the... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073723</comments>
            <pubDate>Thu, 10 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073723</guid>        </item>
        <item>
            <title>Generic drug groups raided</title>
            <link>http://www.medworm.com/index.php?rid=3073722&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff15dda1a-e52d-11de-9a25-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>European competition regulators yesterday launched a fresh set of raids on the premises of some drug companies because of concern about anti-competitive practices... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073722</comments>
            <pubDate>Thu, 10 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073722</guid>        </item>
        <item>
            <title>Democrats agree healthcare compromise</title>
            <link>http://www.medworm.com/index.php?rid=3073721&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff390e08e-e52d-11de-9a25-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The Obama administration's efforts to overhaul the US healthcare system have gathered new momentum, with liberal Democratic senators dropping demands for a broad... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073721</comments>
            <pubDate>Thu, 10 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073721</guid>        </item>
        <item>
            <title>Caretech predicts outsourcing boon</title>
            <link>http://www.medworm.com/index.php?rid=3073720&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F3f0df342-e4db-11de-817b-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The residential care home operator expects further outsourcing of care for people with mental health and learning difficulties due to a squeeze on local authority finances (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073720</comments>
            <pubDate>Thu, 10 Dec 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073720</guid>        </item>
        <item>
            <title>Further doubts voiced on benefit of Tamiflu</title>
            <link>http://www.medworm.com/index.php?rid=3069310&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F8318f51e-e454-11de-a0ea-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Fresh doubt is thrown on the value of Roche's antiviral flu drug Tamiflu after an academic article argues a lack of scientific data 'undermines' claims it prevents complications (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3069310</comments>
            <pubDate>Wed, 09 Dec 2009 00:02:44 +0100</pubDate>
            <guid isPermaLink="false">3069310</guid>        </item>
        <item>
            <title>Rising care home costs hit Southern Cross</title>
            <link>http://www.medworm.com/index.php?rid=3069311&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F4f439ab2-e415-11de-bed0-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Growing labour, administration and rental costs increase operating losses at the UK's largest operator of care homes, although pre-tax losses fall because of lower finance costs (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3069311</comments>
            <pubDate>Tue, 08 Dec 2009 18:54:18 +0100</pubDate>
            <guid isPermaLink="false">3069311</guid>        </item>
        <item>
            <title>RBS gives up Four Seasons vote rights</title>
            <link>http://www.medworm.com/index.php?rid=3062363&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fdfd5e122-e29c-11de-b028-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Royal Bank of Scotland, which is set to become the single largest shareholder in Four Seasons Healthcare, has given up rights to influence the heavily-indebted UK care home operator (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3062363</comments>
            <pubDate>Sun, 06 Dec 2009 20:00:04 +0100</pubDate>
            <guid isPermaLink="false">3062363</guid>        </item>
        <item>
            <title>Venture capitalists re-emerge for Movetis IPO</title>
            <link>http://www.medworm.com/index.php?rid=3054784&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fcb985af0-e044-11de-8494-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A two-year drought of initial public offerings by venture capital-backed companies in Europe will be broken when the gastrointestinal drugs group floats on Euronext in Brussels (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3054784</comments>
            <pubDate>Fri, 04 Dec 2009 00:01:37 +0100</pubDate>
            <guid isPermaLink="false">3054784</guid>        </item>
        <item>
            <title>Gilead set to benefit from HIV guidelines</title>
            <link>http://www.medworm.com/index.php?rid=3046693&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff8be7820-dea0-11de-adff-00144feab49a.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>US biotech company is poised to benefit from new WHO guidelines for HIV which call for earlier treatment using more up-to-date drugs (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3046693</comments>
            <pubDate>Wed, 02 Dec 2009 12:45:03 +0100</pubDate>
            <guid isPermaLink="false">3046693</guid>        </item>
        <item>
            <title>Drugs groups face increase in tax rates</title>
            <link>http://www.medworm.com/index.php?rid=3042413&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fec2cd406-dde9-11de-b8e2-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>PwC says rising public sector deficits and a shift in the strategy of pharmaceutical companies will intensify countries' efforts to clamp down on methods used to keep taxes low (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3042413</comments>
            <pubDate>Tue, 01 Dec 2009 00:55:30 +0100</pubDate>
            <guid isPermaLink="false">3042413</guid>        </item>
        <item>
            <title>Tests boosts Immunodiagnostic Systems</title>
            <link>http://www.medworm.com/index.php?rid=3042414&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fb0be09dc-dda6-11de-9f8b-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The surging popularity of vitamin D tests has lifted profits at the medical testing company as it promotes a new system that will greatly increase medical diagnosis (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3042414</comments>
            <pubDate>Mon, 30 Nov 2009 19:32:26 +0100</pubDate>
            <guid isPermaLink="false">3042414</guid>        </item>
        <item>
            <title>GSK to cut drug prices for developing countries</title>
            <link>http://www.medworm.com/index.php?rid=3038209&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F9848b498-dd14-11de-ad60-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK drugs maker is to cut signi­ficantly the prices of its medicine in emerging economies next spring, in a move to tap demand from the faster-growing economies as western markets stagnate (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038209</comments>
            <pubDate>Sun, 29 Nov 2009 22:30:47 +0100</pubDate>
            <guid isPermaLink="false">3038209</guid>        </item>
        <item>
            <title>Warning sounded over drug tenders</title>
            <link>http://www.medworm.com/index.php?rid=3038210&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fbf5ca778-dd24-11de-ad60-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Large-scale government tenders for generic medicines are threatening the future of the off-patent pharmaceuticals industry, the new president of the trade body has warned (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038210</comments>
            <pubDate>Sun, 29 Nov 2009 21:50:55 +0100</pubDate>
            <guid isPermaLink="false">3038210</guid>        </item>
        <item>
            <title>Turning the world of drugs upside down</title>
            <link>http://www.medworm.com/index.php?rid=3038211&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F0670e678-dd03-11de-ad60-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>When Abbas Hussain was recruited by GlaxoSmith-Kline's chief executive Andrew Witty last year to head emerging markets, the idea was to shift the pharmaceutical company away from 'white pills in western markets' (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038211</comments>
            <pubDate>Sun, 29 Nov 2009 17:42:30 +0100</pubDate>
            <guid isPermaLink="false">3038211</guid>        </item>
        <item>
            <title>Glaxo hopes high for Cambridge science centre</title>
            <link>http://www.medworm.com/index.php?rid=3038212&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F9e2e0bd2-dcf7-11de-ad60-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>GlaxoSmithKline is to spearhead the development of a £170m biotech science park in an effort to create a life sciences cluster in the east of England that can rival the leading US centres of Boston and North Carolina (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038212</comments>
            <pubDate>Sun, 29 Nov 2009 16:18:50 +0100</pubDate>
            <guid isPermaLink="false">3038212</guid>        </item>
        <item>
            <title>Milestone payments boost Vectura</title>
            <link>http://www.medworm.com/index.php?rid=3035326&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F8a0e026e-db36-11de-9023-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Revenues at the drug delivery group jump 71% to £22.8m, helped by a jump in milestone payments from pharma groups and increased royalties on its marketed products (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3035326</comments>
            <pubDate>Sat, 28 Nov 2009 02:01:17 +0100</pubDate>
            <guid isPermaLink="false">3035326</guid>        </item>
        <item>
            <title>Pfizer takes aim in patent row</title>
            <link>http://www.medworm.com/index.php?rid=3025025&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F19afde18-d922-11de-b2d5-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The US pharmaceutical group alleges patent infringement against the largest drugsmaker in the Philippiness (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3025025</comments>
            <pubDate>Tue, 24 Nov 2009 23:35:24 +0100</pubDate>
            <guid isPermaLink="false">3025025</guid>        </item>
        <item>
            <title>Forgetful patients lift support consultancies</title>
            <link>http://www.medworm.com/index.php?rid=3025026&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fcad63d0c-d929-11de-b2d5-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A growing number of companies are being sought out by pharmaceutical groups as they explore strategic ways to improve patient &quot;adherence&quot; (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3025026</comments>
            <pubDate>Tue, 24 Nov 2009 23:03:38 +0100</pubDate>
            <guid isPermaLink="false">3025026</guid>        </item>
        <item>
            <title>Sanofi chief lays out distinctive strategy</title>
            <link>http://www.medworm.com/index.php?rid=3018014&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd461b6ac-d790-11de-b578-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The chief executive of Sanofi-Aventis criticises the past dominance of science over commerce in the French pharmaceuticals group and the stifling of the companies it acquired, as he lays out a distinctive strategy almost one year into the job (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3018014</comments>
            <pubDate>Sun, 22 Nov 2009 19:51:22 +0100</pubDate>
            <guid isPermaLink="false">3018014</guid>        </item>
        <item>
            <title>J&amp;J stays true to its diversified model</title>
            <link>http://www.medworm.com/index.php?rid=3014280&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd6e0a888-d606-11de-b80f-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Johnson &amp; Johnson defends its strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals, even as the approach fails to shield it from industry pains (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3014280</comments>
            <pubDate>Fri, 20 Nov 2009 20:39:24 +0100</pubDate>
            <guid isPermaLink="false">3014280</guid>        </item>
        <item>
            <title>Philip Morris ordered to pay $300m to smoker</title>
            <link>http://www.medworm.com/index.php?rid=3010748&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F94d403da-d57b-11de-81ee-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A Florida jury orders cigarette maker Philip Morris USA to pay $300m in damages to a 61-year-old ex-smoker who is wheelchair-bound by emphysema (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3010748</comments>
            <pubDate>Fri, 20 Nov 2009 02:33:47 +0100</pubDate>
            <guid isPermaLink="false">3010748</guid>        </item>
        <item>
            <title>Under-fives get swine flu jabs</title>
            <link>http://www.medworm.com/index.php?rid=3010750&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fd4396ada-d574-11de-81ee-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Children under five will be the next group to be given priority in receiving the swine flu vaccine, Sir Liam Donaldson, the chief medical officer, said yesterday. The... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3010750</comments>
            <pubDate>Fri, 20 Nov 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3010750</guid>        </item>
        <item>
            <title>Cheap does not mean cheerful, says Toys R Us</title>
            <link>http://www.medworm.com/index.php?rid=3010749&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F0608ea72-d575-11de-81ee-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>This year's hard-to-find Christmas toy in the US, the Zhu Zhu Pets robotic hamster, costs about $10. But as he flips through Toys R Us's annual catalogue at the... (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3010749</comments>
            <pubDate>Fri, 20 Nov 2009 02:00:00 +0100</pubDate>
            <guid isPermaLink="false">3010749</guid>        </item>
        <item>
            <title>Regulations trim growth at United Drug</title>
            <link>http://www.medworm.com/index.php?rid=3006342&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F84f26952-d427-11de-990c-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>Reduced prices in its main Irish markets have crimped sales growth at the healthcare products supplier, in spite of strong growth in its contract sales and drug packaging businesses (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3006342</comments>
            <pubDate>Thu, 19 Nov 2009 01:54:51 +0100</pubDate>
            <guid isPermaLink="false">3006342</guid>        </item>
        <item>
            <title>Property concerns prompt NHS probe</title>
            <link>http://www.medworm.com/index.php?rid=3006343&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fde0a4a46-d477-11de-a935-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>An inquiry is being opened into how far the health service should retain control of its property when it puts services out to tender or allows mergers and takeovers (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3006343</comments>
            <pubDate>Wed, 18 Nov 2009 23:15:33 +0100</pubDate>
            <guid isPermaLink="false">3006343</guid>        </item>
        <item>
            <title>GSK deal draws smokers' vaccine closer</title>
            <link>http://www.medworm.com/index.php?rid=2997967&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Ff32e2cb4-d2fe-11de-af63-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The NicVAX vaccine moved closer to the market after a deal between GlaxoSmithKline and the US biotech company Nabi Pharmaceuticals, which developed the product (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2997967</comments>
            <pubDate>Mon, 16 Nov 2009 22:32:56 +0100</pubDate>
            <guid isPermaLink="false">2997967</guid>        </item>
        <item>
            <title>GSK plans to cut drug production waste</title>
            <link>http://www.medworm.com/index.php?rid=2994746&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2Fc2652114-d20e-11de-a0f0-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>The UK-based pharmaceutical group has set a target to cut by two-thirds the waste generated by medicines production (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2994746</comments>
            <pubDate>Sun, 15 Nov 2009 22:23:34 +0100</pubDate>
            <guid isPermaLink="false">2994746</guid>        </item>
        <item>
            <title>Grandma knows best when it comes to drugs</title>
            <link>http://www.medworm.com/index.php?rid=2991046&amp;cid=s_22563_34_f&amp;fid=22563&amp;url=http%3A%2F%2Ftraxfer.ft.com%2Fcms%2Fs%2F0%2F3f89e3ac-d07d-11de-af9c-00144feabdc0.html%3Fo%3D%252Frss%252Fcompanies%252Fhealth</link>
            <description>A small cluster of British drug companies is marketing drugs that are decades old, relying on consumers' affection for products that they probably first saw in their grandparents' medicine chest (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2991046</comments>
            <pubDate>Sat, 14 Nov 2009 00:21:16 +0100</pubDate>
            <guid isPermaLink="false">2991046</guid>        </item>
    </channel>
</rss>
